Suraj Kalia
Stock Analyst at Oppenheimer
Total Price Targets
19
Stocks Covered
13
Sectors
Healthcare
Most Recent
Feb 20, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Suraj Kalia
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| PLSE | Pulse Biosciences, Inc. | $30.00 | $20.79 | +44.3% | 1 | Feb 20, 2026 |
| AORT | Artivion, Inc. | $50.00 | $36.24 | +38.0% | 2 | Nov 7, 2025 |
| TNDM | Tandem Diabetes Care, Inc. | $22.00 | $19.34 | +13.8% | 1 | Sep 8, 2025 |
| BSX | Boston Scientific Corporation | $125.00 | $56.91 | +119.7% | 1 | Sep 8, 2025 |
| PRCT | PROCEPT BioRobotics Corporation | $60.00 | $24.27 | +147.2% | 1 | Sep 2, 2025 |
| IRTC | iRhythm Technologies, Inc. | $120.00 | $119.47 | +0.4% | 2 | Jan 8, 2025 |
| TMDX | TransMedics Group, Inc. | $125.00 | $100.16 | +24.8% | 2 | Oct 29, 2024 |
| ABT | Abbott Laboratories | $130.00 | $89.76 | +44.8% | 1 | Oct 8, 2024 |
| EW | Edwards Lifesciences Corporation | $90.00 | $84.24 | +6.8% | 3 | Jul 25, 2024 |
| ATRC | AtriCure, Inc. | $32.00 | $29.16 | +9.7% | 1 | Apr 23, 2024 |
| RMD | ResMed Inc. | $175.00 | $205.50 | -14.8% | 2 | Oct 27, 2023 |
| LMAT | LeMaitre Vascular, Inc. | $70.00 | $111.47 | -37.2% | 1 | Sep 6, 2023 |
| GEHC | GE HealthCare Technologies Inc. | $97.00 | $61.13 | +58.7% | 1 | May 16, 2023 |
Recent Activity
- Feb 20, 2026— Set$30.00price target onPLSE(Pulse Biosciences, Inc.)
- Nov 7, 2025— Set$50.00price target onAORT(Artivion, Inc.)
- Sep 8, 2025— Set$22.00price target onTNDM(Tandem Diabetes Care, Inc.)
- Sep 8, 2025— Set$125.00price target onBSX(Boston Scientific Corporation)
- Sep 2, 2025— Set$60.00price target onPRCT(PROCEPT BioRobotics Corporation)
- Jan 8, 2025— Set$120.00price target onIRTC(iRhythm Technologies, Inc.)
- Oct 29, 2024— Set$125.00price target onTMDX(TransMedics Group, Inc.)
- Oct 8, 2024— Set$130.00price target onABT(Abbott Laboratories)
- Aug 9, 2024— Set$30.00price target onAORT(Artivion, Inc.)
- Aug 2, 2024— Set$145.00price target onIRTC(iRhythm Technologies, Inc.)
- Aug 1, 2024— Set$200.00price target onTMDX(TransMedics Group, Inc.)
- Jul 25, 2024— Set$90.00price target onEW(Edwards Lifesciences Corporation)
- Apr 23, 2024— Set$32.00price target onATRC(AtriCure, Inc.)
- Mar 18, 2024— Set$100.00price target onEW(Edwards Lifesciences Corporation)
- Oct 27, 2023— Set$175.00price target onRMD(ResMed Inc.)
- Sep 6, 2023— Set$70.00price target onLMAT(LeMaitre Vascular, Inc.)
- May 16, 2023— Set$97.00price target onGEHC(GE HealthCare Technologies Inc.)
- Dec 9, 2021— Set$135.00price target onEW(Edwards Lifesciences Corporation)
- Oct 14, 2021— Set$312.00price target onRMD(ResMed Inc.)
Frequently Asked Questions
Who is Suraj Kalia?
Suraj Kalia is a stock analyst at Oppenheimer covering 13 stocks primarily in Healthcare. They have issued 19 price targets since Oct 14, 2021.
What stocks does Suraj Kalia cover?
Suraj Kalia currently covers 13 stocks, including EW, AORT, IRTC, TMDX, RMD.
What is Suraj Kalia's latest price target?
Suraj Kalia's most recent price target was $30.00 on PLSE (Pulse Biosciences, Inc.), set on Feb 20, 2026.
What is Suraj Kalia's highest price target?
Suraj Kalia's highest issued price target is $312.00 on RMD, set on Oct 14, 2021.
More Analysts at Oppenheimer
Coverage based on publicly published price targets. Not investment advice.